Items where authors include "Garg, S."

Article

Garg, S., Singla, P., Kaur, S. et al. (7 more authors) (2025) Future perspectives on the automation and biocompatibility of molecularly imprinted polymers for healthcare applications. Macromolecules, 58 (3). pp. 1157-1168. ISSN 0024-9297

Singla, P., Broughton, T., Sullivan, M.V. orcid.org/0000-0002-1771-8268 et al. (10 more authors) (2024) Double imprinted nanoparticles for sequential membrane‐to‐nuclear drug delivery. Advanced Science, 11 (36). 2309976. ISSN 2198-3844

Sidhu, J.K., Siggins, M.K. orcid.org/0000-0003-2504-6518, Liew, F. orcid.org/0000-0002-8736-9198 et al. (400 more authors) (2024) Delayed mucosal antiviral responses despite robust peripheral inflammation in fatal COVID-19. The Journal of Infectious Diseases, 230 (1). e17-e29. ISSN 0022-1899

Liew, F., Efstathiou, C. orcid.org/0000-0001-6125-8126, Fontanella, S. et al. (1457 more authors) (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25 (4). pp. 607-621. ISSN 1529-2908

Michael, B.D. orcid.org/0000-0002-8693-8926, Dunai, C. orcid.org/0000-0001-5799-2387, Needham, E.J. orcid.org/0000-0001-7042-7462 et al. (559 more authors) (2023) Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nature Communications, 14 (1). 8487. ISSN 2041-1723

Goldswain, H., Dong, X., Penrice-Randal, R. et al. (405 more authors) (2023) The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection. Genome Biology, 24 (1). 47. ISSN 1474-7596

Liew, F. orcid.org/0000-0002-8736-9198, Talwar, S., Cross, A. et al. (1439 more authors) (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. eBioMedicine, 87. 104402. ISSN 2352-3964

Stables, R.H., Mullen, L.J., Elguindy, M. et al. (23 more authors) (2022) Routine pressure wire assessment versus conventional angiography in the management of patients with coronary artery disease : the RIPCORD 2 Trial. Circulation, 146 (9). pp. 687-698. ISSN 0009-7322

Ono, M., Onuma, Y., Kawashima, H. et al. (24 more authors) (2022) Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention : insights from the GLOBAL LEADERS trial. Catheterization and Cardiovascular Interventions, 100 (1). pp. 72-82. ISSN 1522-1946

Millar, J.E., Neyton, L., Seth, S. et al. (263 more authors) (2022) Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study. Scientific Reports, 12. 6843. ISSN 2045-2322

Ono, M., Chichareon, P., Tomaniak, M. et al. (26 more authors) (2020) The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention : a prespecified sub-analysis of the GLOBAL LEADERS trial. Clinical Research in Cardiology, 109 (9). pp. 1125-1139. ISSN 1861-0684

Battelino, T., Danne, T., Bergenstal, R.M. et al. (39 more authors) (2019) Clinical targets for continuous glucose monitoring data interpretation : recommendations from the international consensus on time in range. Diabetes Care, 42 (8). pp. 1593-1603. ISSN 0149-5992